Cargando…

Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model

Monoamine oxidase B (MAO-B) is an enzyme that metabolizes several chemicals, including dopamine. MAO-B inhibitors are used in the treatment of Parkinson’s Disease (PD), and the inhibition of this enzyme reduces dopamine turnover and oxidative stress. The absence of dopamine results in PD pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arslan, Mehmet Enes, Türkez, Hasan, Sevim, Yasemin, Selvitopi, Harun, Kadi, Abdurrahim, Öner, Sena, Mardinoğlu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093699/ https://www.ncbi.nlm.nih.gov/pubmed/37048065 http://dx.doi.org/10.3390/cells12070992

Ejemplares similares

Lipoic Acid Conjugated Boron Hybrids Enhance Wound Healing and Antimicrobial Processes
por: Türkez, Hasan, et al.
Publicado: (2022)

Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents
por: Gouleni, Niki, et al.
Publicado: (2023)

Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer’s Disease Treatment
por: Yıldırım, Özge Çağlar, et al.
Publicado: (2022)

Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity
por: Aydin, Nursah, et al.
Publicado: (2022)

Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration
por: Cinici, Emine, et al.
Publicado: (2021)

Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates
por: Turkez, Hasan, et al.
Publicado: (2020)

Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition
por: Whipple, Rebecca A, et al.
Publicado: (2013)

Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives
por: Turkez, Hasan, et al.
Publicado: (2022)

In Vitro Transcriptome Analysis of Cobalt Boride Nanoparticles on Human Pulmonary Alveolar Cells
por: Arslan, Mehmet Enes, et al.
Publicado: (2022)

Amelioration of Benign Prostatic Hyperplasia by Costunolide and Dehydrocostus Lactone in Wistar Rats
por: Choi, Dohyun, et al.
Publicado: (2021)

The Assessment of Selected miRNA Profile in Familial Mediterranean Fever
por: Kahraman, Cigdem Yuce, et al.
Publicado: (2021)

The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells
por: ÇADIRCI, Kenan, et al.
Publicado: (2020)

Molecular Genetics and Cytotoxic Responses to Titanium Diboride and Zinc Borate Nanoparticles on Cultured Human Primary Alveolar Epithelial Cells
por: Türkez, Hasan, et al.
Publicado: (2022)

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases
por: Lam, Simon, et al.
Publicado: (2021)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Boron Compounds Exhibit Protective Effects against Aluminum-Induced Neurotoxicity and Genotoxicity: In Vitro and In Vivo Study
por: Turkez, Hasan, et al.
Publicado: (2022)

Bu-Yin-Qian-Zheng Formula Ameliorates MPP(+)-Induced Mitochondrial Dysfunction in Parkinson’s Disease via Parkin
por: Ma, Hao-Jie, et al.
Publicado: (2020)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
por: Bayraktar, Abdulahad, et al.
Publicado: (2023)

Reconstitution of the Costunolide Biosynthetic Pathway in Yeast and Nicotiana benthamiana
por: Liu, Qing, et al.
Publicado: (2011)

Potential Anti-Cancer Activities and Mechanisms of Costunolide and Dehydrocostuslactone
por: Lin, Xuejing, et al.
Publicado: (2015)

Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease
por: Turkez, Hasan, et al.
Publicado: (2021)

Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies
por: Tozlu, Özlem Özdemir, et al.
Publicado: (2022)

Da-Bu-Yin-Wan and Qian-Zheng-San Ameliorate Mitochondrial Dynamics in the Parkinson’s Disease Cell Model Induced by MPP(+)
por: Gai, Cong, et al.
Publicado: (2019)

The Alteration of Nasopharyngeal and Oropharyngeal Microbiota in Children with MPP and Non-MPP
por: Lu, Zhiwei, et al.
Publicado: (2017)

Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
por: Yulug, Burak, et al.
Publicado: (2023)

Multi-parameter Behavioral Phenotyping of the MPP+ Model of Parkinson’s Disease in Zebrafish
por: Christensen, Christian, et al.
Publicado: (2020)

LINC00667 regulates MPP(+)‐induced neuronal injury in Parkinson’s disease
por: Huo, Xinlong, et al.
Publicado: (2022)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Multi-omics approaches for revealing the complexity of cardiovascular disease
por: Doran, Stephen, et al.
Publicado: (2021)

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
por: Kaynar, Ali, et al.
Publicado: (2021)

Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
por: Kim, Woonghee, et al.
Publicado: (2023)

Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
por: Kim, Dae Yong, et al.
Publicado: (2019)

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
por: Liao, Xinmeng, et al.
Publicado: (2023)

Informing Pharmacokinetic Models With Physiological Data: Oral Population Modeling of L-Serine in Humans
por: Bosley, J. R., et al.
Publicado: (2021)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

2013 MPP Workshop
por: Jonker, Michael
Publicado: (2014)

The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020)

Therapeutic Effect of Costunolide in Autoimmune Hepatitis: Network Pharmacology and Experimental Validation
por: Huang, Zheng, et al.
Publicado: (2023)

Characteristics of the mitochondrial and cellular uptake of MPP(+), as probed by the fluorescent mimic, 4'I-MPP(+)
por: Mapa, Mapa S. T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0sb86jb3murt1ssj1h1jp3dcg5